Elsevier, the information analytics business specialising in science and health, has announced the launch of Entellect, a new cloud-based data platform designed to help life sciences companies overcome the challenges of modern R&D by enriching and harmonising proprietary and external data and delivering it in an AI-ready environment.
With nearly a fifth of pharmaceutical spending going to R&D and the average cost of bringing a new drug to market estimated at $4 billion USD, life sciences companies urgently need more efficient ways to analyse data. Drawing on its longstanding experience in the life sciences, Elsevier has created Entellect. This new platform can save time and costs by de-siloing, contextualising and connecting drug, target, and disease data to deliver normalised, discoverable and model-ready information.
Entellect allows researchers to produce far more accurate predictive models across a range of pre- and post-market activities, including drug efficacy studies, risk-benefit analyses and pharmacovigilance activities. Some of the key attributes of Entellect include alignment and integration with Elsevier's high-quality data and ontologies; engineered for flexibility and scale - not a "one technology" solution, so building custom applications is easy; incorporates a full-data scientist development stack, so data scientists can work on solving problems not manipulating the data; built on Elsevier's heritage of rigorous data governance processes, so users can choose what data to trust in their analyses; open platform for collaboration, data and application sharing; frictionless ingestion of disparate content from multiple sources - such as websites, LIMS, archives, and applications - along with text and data mining of that content; and creation of rich knowledgebases of harmonised and linked data through connection of various sources, including Elsevier databases such as Reaxys, Pharmapendium or Embase.
Entellect is already being used by Elsevier clients to gather, cleanse and connect more than 10,000 different unstructured medical documents in various formats to make them standardised and searchable. Entellect's taxonomy capabilities allow users to search across various fields including drug names, targets and diseases.
Entellect is a smart and versatile life sciences platform that empowers R&D by leveraging Elsevier's trusted approach to data integration and harmonisation. Entellect delivers connected and AI-ready data by linking and enriching disparate content against established life science taxonomies. Combined with the option of Elsevier data, the result is a scalable and customisable knowledge environment, enabling exploratory and predictive analytics applications.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
